Redox-responsive liposomes aimed at nitroreductase for contents release

Area of Science:

• Biomedical Engineering
• Drug Delivery Systems
• Nanotechnology

Background:

• Developing stimuli-responsive liposomes for targeted cancer therapy is crucial.
• Redox-sensitive liposomes aim to release drugs specifically in tumor microenvironments.
• Nitroreductase (NTR) is often overexpressed in tumor tissues, making it a target for drug release mechanisms.

Purpose of the Study:

• To construct and evaluate novel N-DOPE liposomes designed for redox-triggered drug release in malignant tumors.
• To investigate the mechanism of payload release from N-DOPE liposomes in response to nitroreductase.
• To identify factors influencing the efficacy of redox-sensitive liposomes as drug carriers.

Main Methods:

• Synthesis of N-DOPE liposomes with a redox-active 4-nitrobenzyl formate head group.
• Testing drug release using calcein as a model payload under various conditions (Na₂S₂O₄, NTR, temperature, aerobic/anaerobic).
• Spectroscopic methods to analyze the formation of azo bonds and understand the reduction pathway.

Main Results:

• N-DOPE liposomes did not release encapsulated calcein payload under tested conditions, even with Na₂S₂O₄ and NTR.
• Azo bond formation was identified as the inhibitory factor preventing complete nitro group reduction to amine, thus blocking payload release.
• Addition of an organic group containing nitro during reduction with Na₂S₂O₄ led to a 45% release of liposomal content.

Conclusions:

• The designed N-DOPE liposomes, as initially hypothesized, did not achieve complete payload release due to azo bond formation.
• The formation of an azo bond impedes the intended 1,6 elimination mechanism for drug release.
• Modifying the reduction process by adding a nitro-containing organic group shows potential for achieving partial drug release, warranting further investigation for optimized drug delivery.